# Antibiotics-Induced Intracranial Hypertension: A Case Report With Literature Review

**Authors:** Mariam Assardoun, Yahya Naji, Soumia Nedday, Sara Laadami, Nawal Adali

PMC · DOI: 10.7759/cureus.55424 · Cureus · 2024-03-03

## TL;DR

A 19-year-old patient developed intracranial hypertension after receiving antibiotics, and symptoms improved after treatment with methylprednisolone and topiramate.

## Contribution

This case report adds to the understanding of antibiotic-induced intracranial hypertension and its successful management.

## Key findings

- The patient showed regression of headaches and papilledema after treatment.
- MRI revealed indirect signs of intracranial hypertension.
- CSF pressure was elevated at 290 mmHg with normal CSF and blood tests.

## Abstract

Idiopathic intracranial hypertension (IIH) is a rare condition characterized by increased intracranial pressure, with an unknown cause. However, the pathophysiology of antibiotic-induced IIH remains unclear. The clinical symptoms include headache, visual disturbances, and vomiting. The diagnosis is confirmed by an elevated intracranial pressure (ICP) with normal CSF study and cerebral imaging. Management includes discontinuing the offending antibiotic and reducing ICP with medications such as acetazolamide or diuretics. Therefore, surgical intervention may be necessary in severe cases.

In this article, we report the case of a 19-year-old patient, admitted with symptoms of intracranial hypertension syndrome, occurring three days after receiving antibiotics (gentamicin, penicillin). Physical examination revealed bilateral optic disc edema. Cerebral magnetic resonance imaging (MRI) revealed indirect signs of intracranial hypertension. The CSF pressure measurement was approximately 290 mmHg, while CSF and other laboratory blood tests were normal. The patient received methylprednisolone bolus and topiramate (50 mg/day). A month later, the clinical outcome showed regression of headaches and regression of the papilledema.

## Linked entities

- **Chemicals:** gentamicin (PubChem CID 3467), penicillin (PubChem CID 2349), methylprednisolone (PubChem CID 6741), topiramate (PubChem CID 5284627), acetazolamide (PubChem CID 1986)
- **Diseases:** intracranial hypertension (MONDO:0006810), idiopathic intracranial hypertension (MONDO:0009468)

## Full-text entities

- **Diseases:** IIH (MESH:D011559), visual disturbances (MESH:D014786), headache (MESH:D006261), Intracranial Hypertension (MESH:D019586), optic disc edema (MESH:D010211), vomiting (MESH:D014839)
- **Chemicals:** topiramate (MESH:D000077236), penicillin (MESH:D010406), methylprednisolone (MESH:D008775), acetazolamide (MESH:D000086), gentamicin (MESH:D005839)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10985648/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10985648/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC10985648/full.md

---
Source: https://tomesphere.com/paper/PMC10985648